resiquimod has been researched along with Dermatitis, Contact in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balkow, S; Basoglu, Y; Benninghoff, B; Ernst, B; Grabbe, S; Gunzer, M; Hillmer, A; Riemann, H; Scholzen, T; Steinert, M; Sunderkötter, C; Weishaupt, C | 1 |
1 other study(ies) available for resiquimod and Dermatitis, Contact
| Article | Year |
|---|---|
Systemic administration of a TLR7 ligand leads to transient immune incompetence due to peripheral-blood leukocyte depletion.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antigens, Differentiation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Adhesion; Dermatitis, Contact; Endothelium, Vascular; Female; Imidazoles; Immune System; Immunohistochemistry; Leukocyte Rolling; Leukocytes; Leukocytes, Mononuclear; Ligands; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Myeloid Differentiation Factor 88; Receptors, Immunologic; Selectins; Signal Transduction; Time Factors; Toll-Like Receptor 7; Up-Regulation | 2005 |